Form 4: Zai Lab CEO Du Ying Reports Stock Transactions
SEC Form 4
Du Ying, Chairperson and CEO of Zai Lab Ltd, reports acquisition and disposal of American Depositary Shares (ADS) related to vesting of Restricted Share Units (RSUs).
Summary
- Du Ying, the Chairperson and CEO of Zai Lab Ltd, filed a Form 4 detailing changes in beneficial ownership.
- On April 3, 2025, 6,750 ADSs were acquired upon the vesting of Restricted Share Units (RSUs).
- On April 4, 2025, 2,945 ADSs were sold at a price of $33.108 per ADS to cover taxes upon vesting of the RSUs.
- Following these transactions, Du Ying directly owns 479,851 ADSs and 20,250 Restricted Share Units.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by an executive, indicating a neutral sentiment.
Future Outlook
The RSUs vest in equal annual installments over four years beginning on April 3, 2025, subject to continuous service.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, which is common in the pharmaceutical industry where equity compensation is prevalent.
Key Dates
| Date | Description |
|---|---|
| 04/03/2025 | Date of earliest transaction; acquisition of 6,750 ADSs upon vesting of RSUs |
| 04/04/2025 | Sale of 2,945 ADSs at $33.108 per ADS for tax purposes |
| 04/07/2025 | Date of signature for the Form 4 filing |
Keywords
Zai Lab, Du Ying, ADS, American Depositary Shares, RSU, Restricted Share Units, Form 4, Beneficial Ownership, Vesting, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.